Dabigatran, rivaroxaban and warfarin are similarly effective for stroke prevention in patients with atrial fibrillation (AF) and multiple chronic conditions. The findings, from a retrospective US study of Medicare data, extend the evidence for oral anticoagulants in a higher risk group than is typically represented in randomised controlled trials. The study comprised almost 147,000 patients ...
NOACs compared on stroke prevention in AF patients with co-morbidities
By Mardi Chapman
4 Oct 2018